Selective cyclo-oxygenase-2 inhibitors; new anti-inflammatory and analgesic agents;Selektiva hämmare av cyklooxygenas-2: Nya medel mot smärta och inflammation

Lakartidningen

Volumn , Issue 19, 1997, Pages 1797-1801

  Oliw, Ernst ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Box 591   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL; CHEMISTRY; HUMAN; METABOLISM; MOUSE; REVIEW;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; HUMANS; MICE;

EID: 0031557762     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta 1996; 1299: 125-40.
2. DeWitt D, Smith WL. Yes, but do they still get headaches. Cell 1995; 83: 345-8.
3. Smith WL, DeWitt D. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin Nephrol 1995; 15: 179-94.
4. Service RF. Closing in on a stomach-sparing aspirin substitute. Science 1996; 273: 1660.
5. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci US A 1994; 91: 1203-17.
6. Isakson P. Pre-clinical and clinical results with a selective inhibitor of COX-2. Proceedings 10th International conference on prostaglandins and related compounds, Wien, 22-27 September, 1996.
7. Crofford LJ, Wilder RL, Ristimäki AP, Sano H, Remmers EF, Epps HR et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. J Clin Invest 1994; 93: 1095-101.
8. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493-501.
9. Laneuville O, Breuer DK, DeWitt DL, Hla T, Funk CD, Smith WL. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal antiinflammatory drugs. J Pharmacol Exp Ther 1994; 271: 927-34.
10. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995; 83: 483-92.
11. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995; 83: 473-82.
12. Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995; 378: 406-9.
13. Johnson JL, Wimsatt J, Buckel SD, Dyer RD, Maddipati KR. Purification and characterization of prostaglandin H synthase-2 from sheep placental cotyledons. Arch Biochem Biophys 1995; 324: 26-34.
14. Pairet M, Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam Clin Pharmacol 1996; 10: 1-15.